- Home
- KSCP vs BOLD Comparison
KSCP vs BOLD Comparison
Compare KSCP & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KSCP
- BOLD
- Stock Information
- Founded
- KSCP 2013
- BOLD 2018
- Country
- KSCP United States
- BOLD United States
- Employees
- KSCP N/A
- BOLD N/A
- Industry
- KSCP Telecommunications Equipment
- BOLD
- Sector
- KSCP Telecommunications
- BOLD
- Exchange
- KSCP Nasdaq
- BOLD Nasdaq
- Market Cap
- KSCP 35.9M
- BOLD 24.4M
- IPO Year
- KSCP 2022
- BOLD 2024
- Fundamental
- Price
- KSCP $5.59
- BOLD $1.19
- Analyst Decision
- KSCP Strong Buy
- BOLD Buy
- Analyst Count
- KSCP 3
- BOLD 3
- Target Price
- KSCP $15.67
- BOLD $4.00
- AVG Volume (30 Days)
- KSCP 1.0M
- BOLD 105.1K
- Earning Date
- KSCP 08-13-2025
- BOLD 08-11-2025
- Dividend Yield
- KSCP N/A
- BOLD N/A
- EPS Growth
- KSCP N/A
- BOLD N/A
- EPS
- KSCP N/A
- BOLD N/A
- Revenue
- KSCP $11,468,000.00
- BOLD N/A
- Revenue This Year
- KSCP $16.17
- BOLD N/A
- Revenue Next Year
- KSCP $39.02
- BOLD N/A
- P/E Ratio
- KSCP N/A
- BOLD N/A
- Revenue Growth
- KSCP N/A
- BOLD N/A
- 52 Week Low
- KSCP $2.45
- BOLD $1.00
- 52 Week High
- KSCP $28.57
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- KSCP 40.74
- BOLD N/A
- Support Level
- KSCP $7.30
- BOLD N/A
- Resistance Level
- KSCP $10.14
- BOLD N/A
- Average True Range (ATR)
- KSCP 0.97
- BOLD 0.00
- MACD
- KSCP -0.31
- BOLD 0.00
- Stochastic Oscillator
- KSCP 1.09
- BOLD 0.00
About KSCP Knightscope Inc.
Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.